Dev Prasad
Stock Analyst at LUCID CAPITAL MARKETS
(2.78)
# 1,758
Out of 5,124 analysts
5
Total ratings
60%
Success rate
42.39%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Dev Prasad
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CUE Cue Biopharma | Initiates: Buy | $4 | $0.37 | +989.62% | 1 | Aug 25, 2025 | |
| IRD Opus Genetics | Initiates: Buy | $5 | $2.08 | +140.38% | 1 | Jun 17, 2025 | |
| AVTX Avalo Therapeutics | Initiates: Buy | $24 | $15.91 | +50.90% | 1 | Dec 17, 2024 | |
| IBIO iBio, Inc. | Initiates: Buy | $6 | $2.06 | +191.26% | 1 | Dec 17, 2024 | |
| CALC CalciMedica | Initiates: Buy | $13 | $5.71 | +127.67% | 1 | Dec 17, 2024 |
Cue Biopharma
Aug 25, 2025
Initiates: Buy
Price Target: $4
Current: $0.37
Upside: +989.62%
Opus Genetics
Jun 17, 2025
Initiates: Buy
Price Target: $5
Current: $2.08
Upside: +140.38%
Avalo Therapeutics
Dec 17, 2024
Initiates: Buy
Price Target: $24
Current: $15.91
Upside: +50.90%
iBio, Inc.
Dec 17, 2024
Initiates: Buy
Price Target: $6
Current: $2.06
Upside: +191.26%
CalciMedica
Dec 17, 2024
Initiates: Buy
Price Target: $13
Current: $5.71
Upside: +127.67%